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Review Article 
Invasiveness of Pseudomonas aeruginosa and Its Role in Diversity of 
Pseudomonal Infectious Diseases
Yoichi HIRAKATA
Department of Laboratory Medicine, Nagasaki University School of Medicine
 Pseudomonas aeruginosa causes both invasive (bacteremic) 
and chronic non-invasive infections in several organs, re-
sulting in the diversity of infectious diseases. When Madin-
Darby canine kidney (MDCK) monolayers were infected 
with clinical isolates of P. aeruginosa, significantly (P < 
0.001) more blood (30 of 32, 93.7%) than respiratory (25 of 
45, 54.4%) isolates penetrated the epithelial cell monolayers 
by 3 h. Only eight (4 blood and 4 respiratory) isolates were 
cytotoxic and possessed exo U, and passed through the 
monolayer following epithelial cell death associated with 
release of lactose dehydrogenase and a marked drop in 
transepithelial electrical resistance. Thus, invasiveness was 
usually independent of cytotoxicity. The capacity to pene-
trate epithelial cells appears to be a critical determi-
nant of invasiveness in susceptible hosts and may be 
controlled by unknown unique genes. In addition, such in-
vasion determinant(s) are thought to be predominantly ex-
ported by P. aeruginosa via MexAB-OprM, which is one of 
multi-drug resistant (MDR) efflux systems. Hence, MDR ef-
flux systems in P. aeruginosa might be critical for the ef-
flux of virulence factors, in addition to their established 
role of exporting harmful substances such as antibiotics or 
detergents.
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Introduction
 Pseudomonas aeruginosa is a versatile Gram-negative 
bacterium that is an important pathogen in patients 
with compromised immunity, including those with 
cystic fibrosis (CF), neutropenia, thermal burns, and 
AIDS". P. aeruginosa is capable of establishing both 
chronic and acute infections. In patients with CF or 
diffuse panbronchiolitis (DPB), P. aeruginosa is the 
most predominant pathogen'), causes chronic infec-
tion, and is difficult to be eliminated but usually does 
not invade the bloodstream. This organism, however, 
is invasive in other patient groups and causes 
bacteremia associated with high mortality rates, par-
ticularly in those with neutropenia. P. aeruginosa also 
causes several other infections in various organs. 
Thus, this organism develops a diversity of infectious 
diseases (Fig. 1).
Respiratory infections 
                                         Urinary infections 
- chronic persistent infections (i.e., DPB, CF) 
- acute exacerbation 
- pneumonias 
(necrotizing, ventilator-associated, terminal)                      /Biliary nfections 
                      P. aeruginosa 7 
f Corneal infections Systemic infections 
                                     endogenous (primary) septicemia 
                                           (i.e., leukemia, burn) 
Skin/soft tissue infections - secondary septicemia 
                                        - meningitis 
                                      - myelitis
Figure 1. A diversity of infectious diseases caused by P. 
aeruginosa. 
DPB; diffuse panbronchiolitis, CF; cystic fibrosis
 Bacteria have to penetrate epithelial and endothelial 
barriers to invade the bloodstream. In addition to fac-
tors in the host such as immunocompromised status, 
virulence factors of the pathogen could be involved in 
different types of infections induced by P. aeruginosa.
Indeed, human blood isolates of P. aeruginosa cause le-
thal endogenous bacteremia in neutropenic mice in-
duced by cyclophosphamide'"' but human respiratory 
isolates do not''. The animal model used in this study 
(Fig. 2) reflects the important pathophysiological steps 
in authentic human infections, including bacterial 
colonization and invasion. Clinical blood isolates of P. 
aeruginosa have the ability to produce larger amounts 
of exoproducts, including exotoxin A and alkaline pro-
tease, in vitro, than the strains isolated from respira-
tory tract' 6'. The blood isolates penetrate human in-
testinal Caco-2 epithelial cell monolayers to a greater 
degree than do the respiratory isolates''. These pheno-
typic findings suggest that blood isolates carry viru-
lence determinants which confer the invasive phenotype. 
Despite evidence of putative virulence determinants in 
P. aeruginosa, none have been characterized yet. This 
is in contrast to what is known about other invasive 
bacteria such as Yersinia, Listeria monocytogenes, 
Shigella, Salmonella, and Escherichia coli (reviewed in 
reference 8). In this article, the author briefly reviews 
the recent findings in invasiveness of P. aeruginosa, fo-
cusing on the own data in this field.
Figure 2. Endogenous P. aeruginosa bacteremia model in mice. 
Mice were given orally P. aeruginosa in drinking water at the 
concentration of 10' CFU/ml between days 1 and 4. Mice 
were given intraperitoneally 200 mg of ampicillin per kg be-
tween days 1 and 4, and 200 mg of cyclophosphamide per 
kg on days 6, 9, and 12. If the isolate inoculated is invasive, 
the pathogen causes endogenous gut-derived septicemia in 
mice.
Two phenotypes of h aeruginosa: invasive phe-
notype and cytotoxic phenotype
 Recently, it has been reported that P. aeruginosa 
strains can be differentiated into two groups: i) strains 
with a cytotoxic phenotype such as PA 103; and ii) 
strains with an invasive but non-cytotoxic phenotype 
such as PAO 1 ° 101. In these studies, the invasiveness.of 
P. aeruginosa has been evaluated in Madin-Darby ca-
nine kidney (MDCK) cells and corneal epithelial cells 
by gentamicin survival assay""'. Recently, it has also
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been reported that P. aeruginosa strain PA 103 carries 
exoU, while PAO1 lacks it"'. ExoU encodes a 70-kDa 
protein (ExoU)"', which is identical to PepA12'. It is a 
cytotoxin secreted by a type III system (reviewed in 
reference 13) and exerts an acute cytotoxic effect on 
epithelial and phagocytic cells. ExoU is a possible can-
didate for the gene controlling invasiveness; however 
a correlation between its presence and the clinical 
sources of different P. aeruginosa strains has not been 
investigated.
Establishment of MDCK cell monolayer system 
and penetration of representative isolates
We have developed an MDCK cell monolayer penetra-
tion assay","' as an in vitro screening system for 
invasiveness of P. aeruginosa16' (Fig. 3). When grown 
on permeable supports, polarized MDCK cells estab-
lish a monolayer with tight junctions and high 
transmonolayer electrical resistance, akin to Caco-2 
cells"'. Monolayers of polarized MDCK cells were pre-
pared in Transwell filter units containing 0.33-cm' po-
rous filter membranes (3.0-,um pores) in 24-well tissue 
culture plates. Monolayers were infected with bacteria 
by adding 5 a 1 (ca. 3.5 x 10' CFU) freshly grown bac-
teria cultured in L-broth overnight at 37°C. 
 First, P. aeruginosa PAO1'g' and PA10319' were exam-
ined in this system. Salmonella typhimurium SL 134420' 
was used as a positive control. Noninvasive rabbit 
enterotoxigenic E. coli strain RDEC-121, which is posi-
tive for oxidation of lactose, was used as a negative 
control and as an internal control of monolayer 
integrity, since it does not penetrate the monolayer 
unless the tight junctions are disrupted by Ca"-free 
medium"' "'. Some clinical isolates of P. aeruginosa in-
cluded five blood isolates and five respiratory isolates, 
which were previously evaluated in a murine model of 
endogenous septicemia" and Caco-2 cell monolayer 
penetration assay'', were also evaluated. In some ex-
periments, an equal number of E. coli RDEC-1 was 
added with P. aeruginosa isolates or S. typhimurium 
SL1344 at the same time. In these co-infection assay,
    Inoculate bacteria into apical medium 
     ̀' ii1) Penetration assay 
e 
                                  2) Assessment of damage of monolayers 
            :4 3) Gentamicin invasion assay 
Figure 3. Schema of MDCK cell monolayer system.
Yoichi Hirakata : Invasiveness of Pseudomonas
basolateral medium was plated on MacConkey agar 
(Quelab, Montreal, Quebec, Canada) to distinguish lac-
tose-positive E. coli colonies from others. 
 The capacity of P. aeruginosa PAO 1 and PA 103 
to penetrate through MDCK cell monolayers was 
compared with that of S. typhymurium SL1344, and 
E. coli RDEC-1 (Fig. 4). PAO1 was detected in the 
basolateral medium by 3 h after inoculation, as was S. 
typhymurium SL1344, whereas P. aeruginosa strain 
PA103 was not detected until 6 h'"'. E. coli RDEC-1 
was not detected by 12 h, and did not appear in the 
basolateral medium until at least 24 h after inocula-
tion. There was no difference in growth rate between 
P. aeruginosa PAO 1 and PA 103 (data not shown). 
Using the 10 clinical isolates a correlation between 
the data using MDCK and Caco-2 cells" was exam-
ined. Times when bacteria appeared in the basolateral 
medium, and recovery of bacteria from the basolateral 
medium at 3h and 6h after inoculation correlated well 
(r = 0.911, 0.950, and 0.874, respectively) between the 
two cell lines (data not shown).
Figure 4. Bacterial penetration of P. aeruginosa PAO 1 (0) 
and PA 103 (VU), S. typhimurium SL 1344 (F-1), and E. coli 
RDEC-1 through MDCK cell monolayers (reference 16). 
Bacteria were inoculated at 3.5 x 10' CFU/well to the apical 
surfaces of MDCK cell monolayers. The assay was performed 
in triplicate, and results are expressed as an average ± stan-
dard deviation. Noninvasive E. coli RDEC-1 could not be re-
covered from the basolateral medium up to 12 h after inocu-
lation.
Penetration of P. aeruginosa clinical isolates 
through MDCK cell monolayers.
 A total of 77 clinical isolates of P. aeruginosa, in-
cluding 32 blood and 45 respiratory isolates were 
evaluated using the MDCK cell monolayer system de-
scribed above. P. aeruginosa isolates were divided to 
four groups based on clinical site of isolation and 
their capacity to penetrate through MDCK cell 
monolayers (table 1)16'. Of 32 blood isolates of P. 
aeruginosa, 30 (93.7%) were detected in the basolateral 
medium by 3h, as was P. aeruginosa PAO1 and S.
typhymurium SL1344. A total of 24 of 45 respiratory 
isolates of P. aeruginosa (54.4%) were detected in the 
basolateral medium by 3h; this percentage was signifi-
cantly lower than among blood isolates (P < 0.001). 
The average number of bacteria detected in the 
basolateral medium at 3 h in blood isolates was sig-
nificantly greater than the value of respiratory iso-
lates (3.26 ± 5.05 x 103 versus 1.06 ± 1.03 x 103 CFU, 
P < 0.05).
Phenotypes of clinical isolates of P. aeruginosa.
 Serum sensitivity of P. aeruginosa strains was evalu-
ated as previously described22' . P. aeruginosa strains 
p J21) and M223' were used as serum-sensitive and 
-resistant controls , respectively. The motility of 
P. aeruginosa isolates was assessed by the diameter of 
colonial spreading in soft L-agar containing 0.3% agar 
as previously reported"). The presence of surface func-
tional pili on P. aeruginosa strains was confirmed by 
plating a 5-,u1 drop of culture supernatant containing 
4 x 10' particles of bacteriophage P0425' onto a freshly 
spread lawn of bacteria made on L-broth agar as pre-
viously reported24'. 
 Significantly greater numbers of serum-sensitive and 
nonmotile phenotypes were found among respiratory 
isolates than blood isolates (P < 0.001 and P < 0.05, re-
spectively), and in respiratory isolates that were not 
able to penetrate MDCK cell monolayer than other 
groups as defined in table 1 (P < 0.001 and P < 0.005, 
respectively)"). Eight respiratory isolates, which were 
serum-resistant and also motile could not penetrate 
the monolayer by 3h. There was no difference in P04 
phage sensitivity between blood and respiratory iso-
lates (P = 0.559), and among the four groups as de-
fined in table 1 (P = 0.076)16' 
 Most clinical blood isolates penetrated MDCK cell 
monolayers by 3 h, suggesting that they possess viru-
lence determinants capable of inducing bacteremia. It 
appears that serum-resistance and motility may be 
necessary but not sufficient, since several motile se-
rum-resistant respiratory isolates failed to pass 
through the monolayer. Although piliation in P. 
aeruginosa is also thought to be important in the colo-
nization of the CF airway and in the establishment of 
other infections26,2" its significance in the penetration 
of isolates through MDCK cell monolayer was not 
clearly demonstrated in this study (table 1).
Table 1. Penetration of clinical isolates of P. aeruginosa through MDCK cell monolayers, their phenotypes, 
and possession of exoU (reference 16).
Or Capacity to penetrate MDCK Mucoid Serum-sensitive b Nonmotile P04-resistant exo Ugene positive by: Origin Total No. 
cell monolayers by 3 ha Cytotoxic                                                                                          PCR Dot blot
Blood 32 Yes 30 0 1 1 6 3 3 3 
                   No 2 0 0 0 2 1 1 1
Respiratory 45 Yes 24 0 5 1 8 2 2 2 
tract 
                    No 21 3 11 7 6 2 2 2
a Significantly greater numbers of blood than respiratory isolates penetrated MDCK cell monolayer by 3 h (P < 0.001) 
6 Significantly greater number of serum-senstive isolates were found in respiratory isolates than blood isolates (P< 0.001), 
and in respiratory isolates which did not penetrated MDCK cell monolayer (P< 0.001). 
° Significantly greater number of nonmotile isolates were found in respiratory isolates than blood isolates ( P < 0.05), 
 and in respiratory isolates which did not penetrate MDCK cell monolayer (P< 0.005).
Detection of exoU gene and its role in cytotoxicity.
 To quantify cytotoxicity of P. aeruginosa isolates on 
the MDCK cell monolayers, the concentration of lac-
tose dehydrogenase (LDH) released from the MDCK 
cells into the medium in the filter units was 
measured"). Triton X-100 was used as a positive con-
trol to destroy the cells and make LDH release. First, 
the LDH level in both the apical and basolateral me-
dium was measured for monolayers incubated with ei-
ther PAO 1 or PA 103 at several time points after infec-
tion (Fig. 5). Although LDH was not detected by 1 h, 
LDH was released into the apical medium from the 
MDCK monolayer inoculated with PA 103 by 3 h. 
When the MDCK cell monolayer was infected with 
PAO1, LDH was not detected until at least 6 h and 
not in substantial levels until 10 h. LDH was not de-
tected in the basolateral medium until 6 h and 10 h 
after infection with PA 103 and PAO1, respectively. 
Cytotoxic strains were defined as those which caused 
statistically significant levels of LDH release from 
MDCK cell monolayers in apical medium by 6h, as 
compared with spontaneous LDH release. Using this 
definition, 8 of 77 clinical P. aeruginosa isolates (10.4%) 
were cytotoxic. These 8 cytotoxic isolates included 
four blood isolates (B22, B24, B34, and B39) and four 
respiratory isolates (S33, S36, S45, and S50). There 
was no significant difference in cytotoxicity between 
blood and respiratory isolates (P = 0.609). 
 The exoU gene was detected from P. aeruginosa 
isolates by both PCR and dot blot hybridization analy-
sis. Chromosomal DNA was purified from the isolates 
as previously described 29'. The oligonucleotide primers
Hours after bacterial inoculation
Figure 5. LDH released from MDCK cells inoculated with P. 
aeruginosa strains PAO1 and PA 103. 
Cytotoxicity of isolates was evaluated by measuring LDH re-
lease from the cells. The assay was performed in triplicate, 
and results are expressed as an average ± standard devia-
tion. The amount of LDH at 6h after inoculation with PAO1 
was not statistically different from spontaneous LDH release 
without bacterial inoculation (P = 0.2482).
used for PCR detection of the exoU gene were de-
signed from the sequence previously published (11, ac-
cession number U97065) for this study as follows; 
sense, 5'-TAG AAC GCC TAT TGC GCG-3' ; antisense, 
5' CTC GAG CTG CAG CAT TTC-3'. PCR was per-
formed in a final volume of 25 ,u 1 containing 20 ng 
of P. aeruginosa DNA, 20 pmol each primer, 250 , M
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each deoxynucleoside triphosphate, and 1 U of Taq 
polymerase in 20 mM Tris-HC1 (pH 8.4), 50 mM KC1, 
and 1.5 MM MgC12 , as follows: 30 cycles of 1 min at 
94 °C, 1 min at 58 °C, and 1 min at 72 °C, followed by 
final extension at 72 °C for 10 min. A DNA probe for 
dot blot hybridization was prepared by amplification 
of a 572 by fragment of the exoU gene from P. 
aeruginosa PA 103 by PCR as described above and 
was simultaneously labelled with digoxigenin-ll-
uridine-5'-triphosphate (DIG-dUTP)30'. Approximately I 
 
, g of DNA in TE from each of the P. aeruginosa iso-
lates was filtered under vacuum onto positively 
charged nylon membranes by using a 96-well dot-
blot apparatus. The filters were hybridized with the 
DIG-labelled exoU gene fragment and were devel-
oped by chemiluminescence detection as previously 
described ....... 
 Figure 6 shows LDH levels in apical medium for the 
cytotoxic isolates together with isolates showed a 
slight but not statically significant level of LDH (S31, 
S32, S35, and S56). The isolates positive for exoU are 
also indicated in figure 6. The expected 572 by frag-
ment of exoU was detected by PCR from 8 isolates in-
cluding blood isolates B22, B24, B34, and B39, and res-
piratory isolates S33, S36, S45, and S50 (table 1 and 
Fig. 6). All these isolates were also positive for exoU 
by dot blot hybridization (table 1 and Fig. 7). There 
were no strains that showed discrepancies in exoU 
gene detection between PCR and dot blot hybridiza-
tion. Figure 6 also shows that typical invasive iso-
lates, including PAO 1 and blood isolates B15, B16, and 
B51, and non-invasive respiratory isolates such as S3 
and S40 were non-cytotoxic and also were negative 
for exoU. 
 In our study, 8 of 77 clinical isolates of P. aeruginosa 
showed significant cytotoxicity towards MDCK cells 
and all of these isolates carried exoU (table 1, figure 
6)16'. To our knowledge, this is the first report of the 
frequency of exoU in clinical isolates. It has been re-
ported that P. aeruginosa isolates can be differentiated 
into two groups as determined by cytotoxic or inva-
sive phenotype, as previously described 910'. In the cur-
rent study, we could further differentiate clinical iso-
lates of P. aeruginosa into four groups as follows: i) 
invasive and lack exoU (non-cytotoxic), ii) noninvasive 
and carry exoU (cytotoxic), iii) invasive and carry exoU 
(cytotoxic), and iv) noninvasive and lack exoU (non-
cytotoxic). Most blood isolates (27 of 32, 84.5%) and 
fewer respiratory isolates (22 of 45, 48.9%) belonged to 
the first group. One blood (B34) and two respiratory 
(S33 and S50) isolates belonged to the second group. 
Blood isolates, B22, B24, and B39, and respiratory iso-
lates S36 and S45 belonged to the third group. In 
these isolates, B24, which was nonmotile, showed very 
low penetration ability (< 5% of value of PAOI), while 
B22 showed marked penetration ability and was de-
tected from basolateral medium faster than PAO1 
(data not shown). One blood isolate (B38) and 19 of 45 
(42.2%) respiratory isolates belonged to the fourth 
group. This group included all mucoid, and several se-
rum-sensitive, and nonmotile isolates. However, seven 
serum-resistant and also motile respiratory isolates be-
longed to this group.
Figure 6. LDH released from MDCK cells at 6 h after inocu-
lation and exoU gene detection in various P. aeruginosa iso-
lates. 
Cytotoxicity was evaluated by measuring LDH release from 
the cells. ExoU was detected by both PCR and dot blot hy-
bridization. • indicate isolates showed statistically significant 
LDH release (P < 0.05), and El indicate isolates showed not 
statistically significant LDH release compared to spontaneous 
LDH release from monolayers without infection (P > 0.1) All 
isolates carrying exoU showed significant cytotoxicity (P < 
0.05).
Figure 7. Detection of exoU by dot blot hybridization (upper) 
and PCR (lower). 
Hybridization was performed by using a digoxigenin-labelled 
exoU fragment incorporated during PCR for P. aeruginosa 
PA103. PA103, B22, B39, S36, and S50 were positive for exoU 
by both methods. Invasive non-cytotoxic isolates, PAO 1, B15, 
and B16, noninvasive non-cytotoxic isolates S3 and S40 were 
negative for exoU. Four additional clinical isolates (B24, B34, 
S33, and S45) were also positive for the gene by both meth-
ods (text, table 1, and figure 6).
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Influence of P. aeruginosa infection on epithe-
lial cell damages.
 Transmonolayer electrical resistance (TER) was 
measured with a Millicell-ESR apparatus at sequential 
timed intervals. 
 Figure 8 shows the mean values of TER for 
cytotoxic isolates, PA103, S50, and B22, and non-
cytotoxic isolates, PAO1, B15, and B16, with those of 
S. typhymurium SL1344 and E. coli RDEC-1. When 
MDCK cell monolayers were inoculated with E. coli 
RDEC-1, TER decreased slowly over time. The 
changes in TER for non-cytotoxic isolates was quite 
similar to that for S. typhymurium SL1344. TER for 
cytotoxic isolates were significantly lower than those 
for non-cytotoxic isolates between 4 and 12 h (P < 
0.05)16' 
 When either P. aeruginosa PAO1 or B16 was added 
simultaneously to the apical medium with E. coli 
RDEC-1, P. aeruginosa alone was detected in the
basolateral medium at 3 h, while E. coli RDEC-1 did 
not appear until 10 h after inoculation (data not 
shown). Similar results were obtained when the 
monolayer was infected with either P. aeruginosa B15 
or B51 together with E. coli RDEC-1 (data not shown). 
In contrast, when cytotoxic P. aeruginosa strains 
PA 103 or S50, and B22 were each inoculated together 
with E. coli RDEC-1, RDEC-1 was detected at the same 
early time as the P. aeruginosa isolates''. 
 The co-infection study clearly revealed that cytotoxic 
isolates passed through MDCK cell monolayer by dis-
rupting the monolayer, while non-cytotoxic isolates, 
such as PAO 1, B15, B16, and B51, did not markedly 
affect monolayer integrity. The results in TER study 
and LDH assay also supported this. Consequently 
cytotoxic clinical isolates and PA 103 are thought to 
pass through the monolayer following monolayer dis-
ruption due to intoxication.
Role of multidrug efflux systems in the inva-
siveness of P. aeruginosa
Figure 8. Changes of transmonolayer electrical resistance 
after P. aeruginosa infection. 
Transmonolayer electrical resistance (TER) was measured at 
certain time intervals in triplicate, and results were ex-
pressed as an average ± standard deviations of area times 
resistance. Mean of cytotoxic P. aeruginosa isolates, PA103, 
S50 and B22 (0), mean of non-cytotoxic P. aeruginosa iso-
lates, PAO1, B15, and B16 (®), S. typhymurium SL1344 (A), 
and E. coli RDEC-1 (•). Cytotoxic isolates PA103, S50, and 
B22 showed a markedly faster drop in TER compared to 
non-cytotoxic isolates PAO1, B15, and B16 (P < 0.05) between 
4 and 12 h.
 P. aeruginosa is intrinsically resistant to conven-
tional penicillins and cephems due to its low outer 
membrane (OM) permeability coupled to the produc-
tion of an inducible chromosomal & -lactamase, which hy-
drolyzes these ~ -lactamss1 and can become mutationally 
resistant to even newly-developed anti-pseudomonal 
agents"'. In addition to the recent emergence of 
metallo- (3 -lactamase producing P. aeruginosa33', multidrug 
resistant (MDR) efflux systems are becoming recog-
nized as important antimicrobial resistance mecha-
nisms for this organism. To date, four resistance-
nodulation-division (RND) MDR efflux systems have 
been well characterized in P. aeruginosa: MexAB-
OprM34-37 MexCD-OprJ38', MexEF-OprN39', and MexXY/ 
OprM4o,41U (reviewed in reference 42). More recently, an 
additional system, MexJK/OprM has been reported43' 
 Recently, certain studies have suggested a relation-
ship between efflux and virulence in P. aeruginosa. For 
instance, it has been reported that MexAB-OprM ex-
ports homoserine lactones which are involved in quo-
rum sensing (cell-to-cell signaling)44-46) and consequent 
regulation of the expression of a variety of virulence 
determinants. However, the role of efflux systems in 
specific clinical pathogenesis of P. aeruginosa, includ-
ing invasiveness, has not been determined. To gain a 
better understanding the role of efflux in bacterial 
pathogenesis, the invasiveness of P. aeruginosa PAOI 
and its efflux mutants was evaluated using in vitro 
MDCK epithelial cell monolayer penetration. Virulence 
was also investigated in a murine model of
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endogenous P. aeruginosa bacteremia. 
 Both the parent WT strain K767 and strain K1521 
(AmexCD-oprJ) penetrated MDCK monolayers by 3 h, 
whereas K 1119 (AmexAB-oprM) was not detected in the 
basolateral medium until 6 h after infection (Fig. 9)4". 
Strains K767 (WT) and K1521 (AmexCD-oprJ) induced 
lethal endogenous septicemia in mice, whereas strain 
K1119 (AmexAB-oprM) failed to kill any mice (P < 
0.0001, Fig. 10)4". To confirm the role of mexAB-oprM 
in the expression of invasiveness, the AmexAB-oprM 
deletion strain K1119 was complemented with mexAB-
oprM by introducing plasmid pRSP17 carrying the 
genes and examined with strains K767 (WT), K1119 
(AmexAB-oprM), and K 1119/pRK415 (plasmid control). 
K 1119/pRSP 17 (mexAB-oprM complemented strain) 
showed the invasiveness equivalent to WT in both in 
vitro (Fig. 11A) and the animal model (Fig. 1113), while 
plasmid control strain K 1119/pRK415 had the same 
phenotype, which was compromised in its capacity to
Hours after infection
 K767 (WT) ® K1119 (OmexAB-oprM) D K1521 (AmexCD-oprJ)
Figure 9. Penetration of P. aeruginosa strain K767 (WT) and 
its efflux mutants (reference 47). 
Bacteria were inoculated at 3.5 x 106 CFU/well to the apical 
surfaces of MDCK cell monolayers. The assay was performed 











No. of bacteria penetrated 
by 3 h after infection (CFU)
Mortality rate (%)
Figure 11. Penetration of P. aeruginosa strain K767 (WT), 
K 1119 (A mexAB-oprM), and mexAB-oprM complemented strain 
(A) and mortality rates of leukemic mice given the P. 
aeruginosa strains (B) (reference 47). 
Strains K1119/pRSP17 and K1119/pRK415 are K1119 (AmexAB-
oprM), complemented with mexAB-oprM and its plasmid con-
trol, respectively. The assay was performed in triplicate, and 
results are expressed as mean ± SD (A). Data are expressed 
as the mortality rate for each group (at least 10 mice per 
group) given a different P. aeruginosa strain (B). 
penetrate MDCK monolayer (Fig. 10A, P < 0.0001) and 
to kill leukopenic mice (Fig. 11 B, P < 0.0001) as K 1119 
(AmexAB-oprM)4". 
 These findings strongly suggest that invasion 
determinant(s) are predominantly exported by P. 
aeruginosa via MexAB-OprM. Hence, MDR efflux sys-
tems in P. aeruginosa might be critical for the efflux of 
virulence factors, in addition to their established role 
of exporting harmful substances such as antibiotics or 
detergents. It seems practical for bacteria to utilize ef-
flux systems to export virulence determinants and 
physiological products, as a physiological process.
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